Trimethoprim/sulfamethoxazole prophylaxis impairs function of mobilised autologous peripheral blood stem cells

被引：9

作者：

Fuchs, M ^{[1
]}

Scheid, C ^{[1
]}

Schulz, A ^{[1
]}

Diehl, V ^{[1
]}

Söhngen, D ^{[1
]}

机构：

[1] Univ Cologne, Dept Med 1, D-50924 Cologne, Germany

来源：

BONE MARROW TRANSPLANTATION | 2000年 / 26卷 / 07期

关键词：

D O I：

10.1038/sj.bmt.1702586

中图分类号：

Q6 [生物物理学];

学科分类号：

071011 ;

摘要：

引用

页码：815 / 816

页数：2

共 6 条

[1]

GICHERU K, 1981, LANCET, V2, P1112

[2]

IMRIE KR, 1995, BONE MARROW TRANSPL, V15, P267

[3] CIPROFLOXACIN VERSUS TRIMETHOPRIM-SULFAMETHOXAZOLE FOR PROPHYLAXIS OF BACTERIAL-INFECTIONS IN BONE-MARROW TRANSPLANT RECIPIENTS - A RANDOMIZED, CONTROLLED TRIAL [J].

LEW, MA ;

KEHOE, K ;

RITZ, J ;

ANTMAN, KH ;

NADLER, L ;

KALISH, LA ;

FINBERG, R .

JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (01) :239-250

[4] Using at least 5x106/kg CD34+ cells for autologous stern cell transplantation significantly reduces febrile complications and use of antibiotics after transplantation [J].

Scheid, C ;

Draube, A ;

Reiser, M ;

Schulz, A ;

Chemnitz, J ;

Nelles, S ;

Fuchs, M ;

Winter, S ;

Wickramanayake, PD ;

Diehl, V ;

Söhngen, D .

BONE MARROW TRANSPLANTATION, 1999, 23 (11) :1177-1181

[5]

SHEEHAN J, 1981, LANCET, V2, P692

[6]

SHEEHAN J, 1981, LANCET, V2, P1294

← 1 →